ISE Chemicals Corporation

ISE Chemicals Corporation

ICHMF
ISE Chemicals CorporationUS flagOther OTC
24.73
USD
- -
- -
1.26BMarket Cap
ISE Chemicals Corporation
ICHMF
(Other OTC)

Recent

price

24.73

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
292.69
272.81
264.28
311.4
353.59
347.52
278.63
281.22
306.18
330.54
330.63
399.25
501.45
518.21
653.25
770.38
573.09
Revenue per Share
21.71
16.17
25.49
40.28
42.13
25.82
13.81
2.14
11.33
23.36
26.34
34.78
50.25
72.04
99.52
127.51
79.99
Basic EPS, GAAP
31.47
17.87
29.49
0.63
1.66
43.65
8.11
26.44
20.08
12.3
-4.41
-0.18
0.84
48.32
13.01
95.15
- -
Free Cash Flow per Basic Share
5.5
5.99
5.99
7.99
8.99
8.99
8.48
7
6
6.49
7.98
9.98
14.5
21.99
31.99
38.99
- -
Dividend per Share
279.81
290.05
309.59
341.91
375.13
392.05
326.93
392.71
398.2
415.14
433.5
458.38
494.15
544.3
611.98
700.47
572.81
Book Value per Share
334.53
342.99
363.47
403.99
444
460.91
464.77
458.19
459.75
473.86
493.31
521.97
561.84
613.97
685.4
767.15
646.62
Tangible Book Value per Share
51
51
51
51
51
51
51
51
51
51
51
51
51
51
51
51
51
Basic Weighted Avg Shares
14,954
13,935
13,498
15,902
18,052
17,738
14,219
14,348
15,615
16,854
16,859
20,354
25,564
26,413
33,287
39,258
29,188
Sales/Revenue/Turnover
18.01
14.63
20.02
23.93
21.7
13.1
7.54
2.84
10.12
12.21
12.97
13.31
14.7
20.05
23.01
24.16
21.4
Operating Margin (%)
1,241
1,381
1,405
1,274
1,331
1,693
1,661
1,666
1,399
1,356
1,311
1,489
1,812
1,970
1,975
2,046
- -
Depreciation Expense
1,109
826
1,302
2,057
2,151
1,318
705
109
578
1,191
1,343
1,773
2,562
3,672
5,071
6,498
4,074
Net Income, GAAP
41.04
42.2
41.44
36.92
37.7
36.45
31.78
60.57
41.68
34.27
32.43
31.56
28.79
29.37
31.56
28.97
31.11
Effective Tax Rate (%)
7.42
5.93
9.65
12.94
11.92
7.43
4.96
0.76
3.7
7.07
7.97
8.71
10.02
13.9
15.23
16.55
13.96
Profit Margin (%)
9,134
9,869
10,641
11,346
11,899
12,819
13,292
13,723
13,767
14,150
13,998
13,745
15,198
17,335
19,896
23,304
18,372
Working Capital
9
12
18
22
13
9
11
18
12
14
18
19
21
37
37
41
- -
LT Debt
17,261
17,683
18,906
21,058
23,095
23,933
24,094
23,725
23,948
24,715
25,680
27,129
29,218
31,890
35,568
40,069
33,589
Total Equity
8.73
6.36
8.17
11.26
10.41
6
2.95
0.65
3.72
5.32
5.63
6.76
9.1
11.65
14.68
16.83
12.77
Return on Invested Capital (%)
7.52
5.45
8.18
11.92
11.37
6.53
3.72
0.58
2.78
5.58
6.04
7.59
10.29
13.55
16.87
19.12
14.34
Return on Capital (%)
7.99
5.67
8.5
12.36
11.75
6.73
3.84
0.59
2.87
5.74
6.21
7.8
10.55
13.87
17.21
19.43
14.64
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
619
600
600
LT Borrowings
- -
- -
- -
LT Finance Leases
37
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
51
51
51
Market Capitalization
23,593
25,300
26,892

Working Capital

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
24,141
22,662
25,344
Cash, Cash Equivalents & STI
9,720
8,091
8,686
Accounts Receivable, Net
6,692
6,324
7,635
Inventories
7,595
8,153
8,887
Total Current Liabilities
6,806
5,375
6,972
Payables & Accruals
- -
- -
- -
ST Debt
619
600
600
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.38%
9.33%
12.65%
Free Cash Flow
545.81%
1,102.48%
631.37%
Net Income, GAAP
60.41%
37.22%
28.14%
Sales/Revenue/Turnover
9.15%
18.72%
17.94%
Total Cash Common Dividend
18.29%
37.85%
21.9%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,857
8,477
- -
- -
33,287
2025
- -
- -
- -
- -
39,258
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
17.18
- -
- -
- -
99.52
2025
- -
- -
- -
- -
127.51
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
31.99
2025
- -
- -
- -
- -
38.99
2026
- -
- -
- -
- -
- -
Business
ISE Chemicals Corporation engages in the manufacture and sale of chemical products primarily in three core segments: iodine and iodine compounds; natural gas; and metallic compounds. The iodine product line includes prilled iodine (ISEFLO), crude iodine, potassium iodide, sodium iodide, cuprous iodide, hydroiodic acid, and iodine disinfectants marketed under the ISEPHOR, DIASAN CLEAN, and ISEPHOR L brands. These iodine products serve diverse applications in the medical field (such as mouthwash and contrast media), livestock feed additives, disinfectants, agricultural chemicals, automotive safety (airbags and seat belts), and electronic devices including LCDs and developing next-generation semiconductors. The metallic compounds segment offers nickel chloride and cobalt hydroxide used in electronic components and ceramic capacitors essential for compact, high-functionality electronic equipment like smartphones and advanced automobiles. The natural gas segment involves extraction and sale operations related to natural gas. Founded in 1927 and headquartered in Tokyo, Japan, ISE Chemicals operates primarily in Japan with products catering to industrial, agricultural, medical, and consumer markets. In recent developments, ISE Chemicals has reported robust financial results with significant revenue growth in the iodine and natural gas business, reflecting heightened global demand amid agricultural and industrial challenges. The company has been actively investing in research and development to enhance product quality and expand applications, including advancing materials for electronics and semiconductor innovations. In 2024 and 2025, the company has undertaken strategic equity buybacks, signaling confidence in its financial position, and its shares have experienced notable appreciation based on strong earnings growth and positive market sentiment. These operational and financial enhancements demonstrate ISE Chemicals' commitment to sustainable growth and expanding its market presence in specialty chemicals with a focus on innovation and environmental stewardship. ISE Chemicals Corporation continues to strengthen its position in the specialty chemicals industry by leveraging its longstanding expertise in iodine-related products, metallic compounds, and natural gas resources, aligning its business strategy with global industry trends and customer needs in Japan and beyond.